Lenoir, C.; Terrier, J.; Gloor, Y.; Gosselin, P.; Daali, Y.; Combescure, C.; Desmeules, J.A.; Samer, C.F.; Reny, J.-L.; Rollason, V.
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting. J. Pers. Med. 2022, 12, 526.
https://doi.org/10.3390/jpm12040526
AMA Style
Lenoir C, Terrier J, Gloor Y, Gosselin P, Daali Y, Combescure C, Desmeules JA, Samer CF, Reny J-L, Rollason V.
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting. Journal of Personalized Medicine. 2022; 12(4):526.
https://doi.org/10.3390/jpm12040526
Chicago/Turabian Style
Lenoir, Camille, Jean Terrier, Yvonne Gloor, Pauline Gosselin, Youssef Daali, Christophe Combescure, Jules Alexandre Desmeules, Caroline Flora Samer, Jean-Luc Reny, and Victoria Rollason.
2022. "Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting" Journal of Personalized Medicine 12, no. 4: 526.
https://doi.org/10.3390/jpm12040526
APA Style
Lenoir, C., Terrier, J., Gloor, Y., Gosselin, P., Daali, Y., Combescure, C., Desmeules, J. A., Samer, C. F., Reny, J.-L., & Rollason, V.
(2022). Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting. Journal of Personalized Medicine, 12(4), 526.
https://doi.org/10.3390/jpm12040526
